Target intelligence / Profile preview

Sterol O-acyltransferase 2 (SOAT2)

Target
SOAT2
Molecular classification
Enzyme, Transferase, Acyltransferase, Membrane protein
01

Overview

Sterol O-acyltransferase 2 (SOAT2), also known as acyl-CoA:cholesterol acyltransferase 2 (ACAT2), is an endoplasmic reticulum membrane-bound enzyme predominantly expressed in hepatocytes and enterocytes. It plays a critical role in systemic cholesterol homeostasis by catalyzing the esterification of free cholesterol with long-chain fatty acyl-CoA to form cholesteryl esters, which are subsequently packaged into apolipoprotein B-containing lipoproteins (such as VLDL and chylomicrons) or stored as intracellular lipid droplets. Due to its central role in dietary cholesterol absorption and hepatic lipoprotein secretion, SOAT2 is a major therapeutic target for cardiovascular diseases, hypercholesterolemia, and atherosclerosis. Additionally, emerging evidence implicates SOAT2 in cancer progression, particularly in hepatocellular carcinoma, lung adenocarcinoma, and ovarian cancer, where its upregulation helps prevent free cholesterol-induced cytotoxicity and supports tumor cell survival. Pharmacological targeting of SOAT2 has evolved from non-selective dual SOAT1/SOAT2 inhibitors like avasimibe and pactimibe, which faced clinical development challenges, to highly selective SOAT2 inhibitors such as pyripyropene A and its derivatives, which demonstrate robust lipid-lowering and anti-atherosclerotic efficacy with improved safety profiles in preclinical models.

Other names
Acyl-CoA:cholesterol acyltransferase 2ACAT2Cholesterol acyltransferase 2ACACT2ARGP2
02

Mechanism of action

Inhibition of sterol O-acyltransferase 2 activity to reduce cholesterol esterification

03

Biological functions

Lipid metabolismCholesterol esterificationLipoprotein assemblyIntestinal cholesterol absorptionCholesterol homeostasis
04

Disease associations

Cardiovascular diseaseAtherosclerosisHypercholesterolemiaNonalcoholic fatty liver diseaseCancerHepatocellular carcinomaLung adenocarcinomaOvarian cancer
05

Safety considerations

DiarrheaTissue toxicityIntracellular free cholesterol accumulationLipotoxicityAdrenal toxicity
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

SOAT2 expression levelPlasma cholesteryl oleate levelsCholesteryl oleate to cholesteryl linoleate ratio

Beyond the preview

Go deeper on Sterol O-acyltransferase 2 (SOAT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sterol O-acyltransferase 2 (SOAT2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call